143
Views
26
CrossRef citations to date
0
Altmetric
Original Articles

Enterolactone Induces G1-phase Cell Cycle Arrest in Nonsmall Cell Lung Cancer Cells by Downregulating Cyclins and Cyclin-dependent Kinases

, , , , , & show all
Pages 652-662 | Received 16 Mar 2016, Accepted 13 Jan 2017, Published online: 21 Mar 2017

References

  • Dela Cruz CS, Tanoue LT, Matthay RA: Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med 32, 605–644, 2011.
  • Sun S, Schiller JH, Spinola M, Minna JD: New molecularly targeted therapies for lung cancer. J Clin Invest 117, 2740–2750, 2007.
  • Wang H, Khor TO, Shu L, Su ZY, Fuentes F, et al.: Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability. Anticancer Agents Med Chem 12, 1281–1305, 2012.
  • Toure A, Xu XM: Flaxseed lignans: source, biosynthesis, metabolism, antioxidant activity, bio-active components, and health benefits. Compr Rev Food Sci Food Saf 9, 261–269, 2010.
  • Lowcock EC, Cotterchio M, Boucher BA: Consumption of flaxseed, a rich source of lignans, is associated with reduced breast cancer risk. Cancer Causes Control 24, 813–816, 2013.
  • Demark-Wahnefried W, Polascik TJ, George SL, Switzer BR, Madden JF, et al.: Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates on men presurgery. Cancer Epidemiol Biomarkers Prev 17, 3577–3587, 2008.
  • Demark-Wahnefried W, Robertson CN, Walther PJ, Polascik TJ, Paulson DF, et al.: Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen. Urology 63, 900–904, 2004.
  • Thompson LU, Chen JM, Li T, Strasser-Weippl K, Goss PE: Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res 11, 3828–3835, 2005.
  • Serraino M, Thompson LU: The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis. Nutr Cancer 17, 153–159, 1992.
  • Chen JM, Tan KP, Ward WE, Thompson LU: Exposure to flaxseed or its purified lignan during suckling inhibits chemically induced rat mammary tumorigenesis. Exp Biol Med 228, 951–958, 2003.
  • Rickard SE, Yuan YV, Chen J, Thompson LU: Effect of flaxseed and its lignan precursor on MNU-induced mammary tumorigenesis. FASEB J 12, A829–A829, 1998.
  • Jenab M, Thompson LU: The influence of flaxseed and lignans on colon carcinogenesis and beta-glucuronidase activity. Carcinogenesis 17, 1343–1348, 1996.
  • Hernandez-Salazar M, Guevara-Gonzalez R, Cruz-Hernandez A, Guevara-Olvera L, Bello-Perez LA, et al.: Flaxseed (Linum usitatissimum L.) and its total non-digestible fraction influence the expression of genes involved in azoxymethane-induced colon cancer in rats. Plant Foods for Hum Nutr 68, 259–267, 2013.
  • Ansenberger K, Richards C, Zhuge Y, Barua A, Bahr JM, et al.: Decreased severity of ovarian cancer and increased survival in hens fed a flaxseed-enriched diet for 1 year. Gynecol Oncol 117, 341–347, 2010.
  • Lin X, Gingrich JR, Bao WJ, Li J, Haroon ZA, et al.: Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice. Urology 60, 919–924, 2002.
  • Thompson LU, Seidl MM, Rickard SE, Orcheson LJ, Fong HHS: Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr Cancer 26, 159–165, 1996.
  • Thompson LU, Rickard SE, Orcheson LJ, Seidl MM: Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis 17, 1373–1376, 1996.
  • Serraino M, Thompson LU: The effect of flaxseed supplementation on early risk markers for mammary carcinogenesis. Cancer Lett 60, 135–142, 1991.
  • Chen LH, Fang J, Li H, Demark-Wahnefried W, Lin X: Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway. Mol Cancer Ther 6, 2581–2590, 2007.
  • Danbara N, Yuri T, Tsujita-Kyutoku M, Tsukamoto R, Uehara N, et al.: Enterolactone induces apoptosis and inhibits growth of Colo 201 human colon cancer cells both in vitro and in vivo. Anticancer Res 25, 2269–2276, 2005.
  • Xiong XY, Hu XJ, Li Y, Liu CM: Inhibitory effects of enterolactone on growth and metastasis in human breast cancer. Nutr Cancer 67, 1324–1332, 2015.
  • Gerard C, Goldbeter A: The balance between cell cycle arrest and cell proliferation: control by the extracellular matrix and by contact inhibition. Interface Focus 4, 2014.
  • Giacinti C, Giordano A: RB and cell cycle progression. Oncogene 25, 5220–5227, 2006.
  • Dubravka D, Scott DW: Regulation of the G1 phase of the mammalian cell cycle. Cell Res 10, 1–16, 2000.
  • McCann MJ, Gill CI, Linton T, Berrar D, McGlynn H, et al.: Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitro. Mol Nutr Food Res 52, 567–580, 2008.
  • Dukes F, Kanterakis S, Lee J, Pietrofesa R, Andersen ES, et al.: Gene expression profiling of flaxseed in mouse lung tissues-modulation of toxicologically relevant genes. BMC Comp Altern Med 12, 47–57, 2012.
  • Kinniry P, Amrani Y, Vachani A, Solomides CC, Arguiri E, et al.: Dietary flaxseed supplementation ameliorates inflammation and oxidative tissue damage in experimental models of acute lung injury in mice. J Nutr 136, 1545–1551, 2006.
  • Lee JC, Bhora F, Sun J, Cheng G, Arguiri E, et al.: Dietary flaxseed enhances antioxidant defenses and is protective in a mouse model of lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol 294, L255–L265, 2008.
  • Lee JC, Krochak R, Blouin A, Kanterakis S, Chatterjee S, et al.: Dietary flaxseed prevents radiation-induced oxidative lung damage, inflammation and fibrosis in a mouse model of thoracic radiation injury. Cancer Biol Ther 8, 47–53, 2009.
  • Chen LH, Fang J, Li HX, Demark-Wahnefried W, Lin X: Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway. Mol Cancer Ther 6, 2581–2590, 2007.
  • McCann MJ, Rowland IR, Roy NC: Anti-proliferative effects of physiological concentrations of enterolactone in models of prostate tumourigenesis. Mol Nutr Food Res 57, 212–224, 2013.
  • McCann MJ, Gill CIR, Linton T, Berrar D, McGlynn H, et al.: Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitro. Mol Nutr Food Res 52, 567–580, 2008.
  • Saarinen NM, Smeds AI, Penalvo JL, Nurmi T, Adlercreutz H, et al.: Flaxseed ingestion alters ratio of enterolactone enantiomers in human serum. J Nutr Metab, 2010.
  • Hallund J, Ravn-Haren G, Bugel S, Tholstrup T, Tetens I: A lignan complex isolated from flaxseed does not affect plasma lipid concentrations or antioxidant capacity in healthy postmenopausal women. J Nutr 136, 112–116, 2006.
  • Setchell KD, Brown NM, Zimmer-Nechemias L, Wolfe B, Jha P, et al.: Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans. Food Funct 5, 491–501, 2014.
  • Chen J, Thompson LU: Lignan and tamoxifen, alone or in combination, reduce breast cancer cell adhesion, invasion and migration in vitro. Breast Cancer Res Treat 80, 163–179, 2003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.